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Systemic inflammation is very prevalent among critically ill patients, particularly those with extensive tissue injury.
Although downstream mediators (cytokines) and effector cells (phagocytes) have been identified, proximal
mediators originating from injured tissues remained elusive. Alarmins (“danger signals”) released by necrotic/injured
cells have been identified recently and certainly play a role in triggering local and systemic inflammation in critically
ill patients. The most promising alarmin candidates are of mitochondrial origin, i.e. mitochondrial DNA and the
chemotactic factor fMet-Leu-Phe (fMLP). ATP also is released from necrotic tissues and stimulates the assembly of
the inflammasome, leading to the production of proinflammatory cytokines, such as interleukin (IL)-1ß. The
identification of novel alarmins opens new therapeutic avenues for the treatment of severe SIRS, and SIRS-dependent
organ dysfunction.
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Introduction
Clinicians have recognized for a long time that critically
ill patients often present with a stress response associat-
ing tachycardia and tachypnea, together with an “inflam-
matory” response characterized by fever and leukocytosis.
The systemic inflammatory response syndrome (SIRS)
concept was coined in 1991 by the late Roger C. Bone [1].
SIRS criteria were rapidly incorporated into the definition
of sepsis during the first ACCP/SCCM consensus confer-
ence published two decades ago [2]. Sepsis was defined as
bacterial infection with a systemic response, associating at
least two of four SIRS criteria [3]. These definitions, al-
though not perfect, still hold today, and are used in all
sepsis studies, as well as at the bedside. Aside from its use
in the sepsis definition, SIRS was rapidly recognized as a
very prevalent syndrome in intensive care units (ICU),
even in non-infected patients. Up to 93% of surgical
ICU patients were reported to meet SIRS criteria, with
ICU mortality ranging from 7–9% in the absence of an in-
fection [3]. It also was epidemiologically demonstratedCorrespondence: jerome.pugin@unige.ch
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in any medium, provided the original work is pthat SIRS may precede sepsis [4]. Because of its high
prevalence in ICUs and the absence of a clear demonstra-
tion of a link between clinical SIRS and systemic inflam-
mation, some of our colleagues have proposed to abandon
the SIRS concept [5]. Interestingly, new tentative sepsis
definitions also included a “response” item, like in the
PIRO concept (predisposition, infection, response, and
organ dysfunction) [6]. “Symptoms” such as heart rate, re-
spiratory frequency, and band forms were retained in a
PIRO score utile for stratification of critically ill patients
and outcome prediction [7].
It was convincingly shown since the late 1980s that SIRS
in critically ill patients was associated with the circulation
of pro- and anti-inflammatory cytokines, even in the ab-
sence of infection [8]. It also was demonstrated that the
balance of pro/anti-inflammatory mediators was pro-
inflammatory in the inflamed organ (bioactive TNF and
IL-1ß in lungs from ARDS patients, in ascitic fluid during
pancreatitis, etc.) but was found to be anti-inflammatory
in the circulation [9,10]. It was proposed that the normal
response to local infection or tissue injury was to produce
a local inflammatory reaction, attracting effectors phago-
cytes at the site of injuries or infection [11]. In contrast,
an excess of anti-inflammatory mediators (soluble TNFn Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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tion” within the circulatory compartment [11].
Although effector cells and their mediators have been
described during SIRS (phagocytes, cytokines, chemokines)
[12], what lacked in the paradigm of tissue injury-induced
inflammation was the identification of endogenous media-
tors originating from injured tissues that were capable of
generating this inflammatory/immune reaction [13]. It is
the purpose of this review to discuss recent findings in the
field of the pathogenesis of SIRS and the relevance of
novel candidate endogenous danger signals.
The danger theory
The long time prevalent theory of the immune system
was based on tolerance of self-antigens developed mostly
during the fetal life by the deletion of auto-reactive lym-
phocytes in the thymus and bone marrow. In this theory,
only remain during extra utero life immune cells capable
of reacting to non–self antigens preventing autoimmun-
ity, and conferring immunity to microbes and allografts.
Sir Frank Macfarlane Burnet and Peter Medawar were
awarded the Nobel Prize in 1960 for this innovative con-
cept for self-/non–self- discrimination. Ample experi-
mental evidence supported this paradigm; however, it
appeared that it was somewhat reductive and could in-
completely explain various situations of tolerance to foreign
antigens or immune/inflammatory reactions to endogenous
antigens. How to explain with the self-/non–self discrimin-
ation theory the absence of sepsis after tooth brushing
where bacteremia is frequent? Why pregnant women do
not reject their fetus, although half of its antigens coming
from the father should be recognized as non-self? Why lac-
tating women do not reject their breasts despite the expres-
sion in adulthood of “novel” milk proteins? In addition,
because the immune system should be tolerant to self-
antigens, how is autoimmunity explained?
Early in the 1990s, Polly Matzinger came up with the
concept that the immune system did not care about self-
vs. non-self but discriminated antigens based on the fact
that were sensed as dangerous or not [14]. This “danger
theory” may explain why pregnant women do not reject
their nondangerous fetus and lactating women do not
recognize newly expressed milk protein as dangerous.
This also explains why circulating indolent gingival bac-
teria do not generate a sepsis syndrome after tooth
brushing, because they are not seen as danger by our
immune system. In this theory, what is essential for the
immune system to react to an antigen is a signal of tis-
sue injury, sensing the danger [15,16]. For the immune
system to react, two signals are needed: one from the
antigen and another one from tissue suffering. Vaccination
is another example validating the danger model. Vaccines
are usually efficacious only with a certain degree of tissue
injury induced by the irritating effect at the site ofinjection of the adjuvant. The sole injection of the micro-
bial antigen is usually well tolerated and does not induce a
protective immune response. The danger theory was well
captured by Polly Matzinger in an interview given to the
New York Times in 1998: “Imagine a community in which
the police accept anyone they met during elementary
school and kill any new migrant. That's the Self/Nonself
Model. In the Danger Model, tourists and immigrants are
accepted, until they start breaking windows. Only then, do
the police move to eliminate them. In fact, it doesn't matter
if the window breaker is a foreigner or a member of
the community.” [17].
This danger theory also makes a lot of sense to the
intensivist for several reasons [13]. SIRS could arise from
an overwhelmed and systemic inflammatory reaction to
massive release of danger signals from injured tissues.
Examples of such situations in the intensive care unit
are numerous: multiple trauma, pancreatitis, ischemia-
reperfusion injury, shock, massive transfusions, and
major surgery [13]. The devastating effects of sepsis may
be explained by a synergistic activation of the inflamma-
tory/immune system by foreign bacterial antigens and
bacteria-induced tissue injury, further increased by
shock, leading to organ dysfunction [13]. This synergism
also may explain why patients with SIRS have such over-
whelmed responses to bacterial infections acquired during
their ICU stay.
Endogenous danger signals (alarmins)
What was lacking to support the danger theory was the
identification of molecules originating from host cells
signaling tissue injury to the immune system (alarmins,
danger-associated molecular patterns, DAMPs). The def-
inition of an alarmin could be a molecule released by
injured cells/tissues that is capable of producing a local
proinflammatory reaction, and attract to the site of injury
effector cells such as phagocytes [18]. Alarmins not only
may generate tissue inflammation after injury, but they
also could act synergistically with microbial non–self-
antigens to enhance the inflammatory reaction [19]. In
case of massive tissue injury, the local production of alar-
mins could spillover into the circulation and produce sys-
temic symptoms, such as fever, leukocytosis, as well as a
stress humoral and neural response [19]. Leukocytes acti-
vated by alarmins may then relay and amplify the inflam-
matory process through the secretion of cytokines, the
release of molecules, such as enzymes, lipid mediators, re-
active oxygen, and nitrogen species [20]. The importance
of tissue injury and the presence of microbial co-factors
may account for the magnitude of the local vs. systemic
inflammatory response (SIRS), vasodilation, and end-
organ dysfunction.
Alarmins represent nothing less that the missing mo-
lecular link between tissue injury and the inflammatory
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should be molecules present inside of cells sheltered
from the immune system, and only released during
tissue injury, most probably during cells necrosis or
plasma membrane rupture [21]. Indeed, it has been
shown that cell death by apoptosis does not produce
inflammation. In addition, receptors for these danger
signals should exist in leukocytes, and possibly in
other cell types sensing the presence of endogenous
alarmins that have become extracellular.High mobility group box 1 (HMGB1)
Since the appearance of the concept of endogenous dan-
ger signals, several candidate alarmins have been pro-
posed [18]. HMGB1 is a DNA chaperone concentrated
in the cell nucleus first demonstrated to induce cell mi-
gration and differentiation. Its role in the pathogenesis
of sepsis was reported in 1999 by the group of Kevin
Tracey [22] and by others in the context of severe SIRS
[23,24]. These investigators showed that HMGB1 was
released by macrophages stimulated by lipopolysac-
charide (LPS), tumor necrosis factor-α (TNF- α), and
IL-1ß [22] and that high HMGB1 was measured in plasma
from patients with septic shock [25]. Administration of
antibodies to HMGB1 prevented late death in a murine
model of sepsis [22]. In contrast, the injection of recom-
binant HMGB1 increased septic mouse lethality [22].
Since this pioneer work, many groups have shown a
proinflammatory activity of HMGB1 and have identified
putative surface leukocyte receptors for HMGB1 (RAGE,
TLR2, and TLR4) [26,27]. It has been recently well estab-
lished that most of–if not all–the inflammatory activity
was not contained in the HMGB1 protein, but rather in
bacterial contaminants bound to it, explaining TLR-
dependent cell activation, HMGB1 only playing a role of
chaperone for bacterial products, including LPS [28,29].
HMGB1 also can be released from dying cells and become
a potential extracellular danger signal, but its role as an
alarmin remains to be clearly demonstrated [30-32].Heat shock proteins
HSPs are ubiquitous proteins, present in the cytoplasm,
mitochondria, the cell nucleus, and act as molecular cha-
perones for proteins. They can be secreted by stressed
cells and are released by necrotic cells [33]. The potential
pro-inflammatory and immune-inducing effects of extra-
cellular HSPs were first proposed in 1993, later thought to
be mediated by TLR2 and TLR4 receptors. As with
HMGB1, highly purified HSPs lacked cytokine function
[29]. It is now believed that HSPs, like HMGB1, act more
as molecular chaperones for bacterial products (LPS,
flagellin, and lipopeptides) and co-factors for cell activa-
tion to pathogen-associated molecular patterns. Therefore,the role of HSPs and HMGB1 in sterile inflammation and
SIRS remains elusive [28,29].
Other putative alarmins
S100 proteins (also called calgranulins) are a group of
calcium-binding proteins that have been proposed as po-
tential alarmins, particularly those expressed in phago-
cytes (S100A8, -A9, and -A12) through their interaction
with RAGE and TLR4 [34,35]. Again, no evidence exists
to show a clear danger signal effect of these proteins in
the absence of bacterial products. Crystals of uric acid
were shown to induce the assembly of the NALP3
inflammasome, leading to the cleavage of pro-IL-1ß into
mature IL-1ß by caspase-1 [36]. Whereas uric acid is
now recognized as a local danger signal in the pathogen-
esis of gout arthritis, none reported a role of this alarmin
in systemic inflammation. Recently, another alarmin
released by necrotic cells has been proposed: IL-33 [37].
This mediator acts through the receptor ST2 at the sur-
face of CD8+ T cells, enhancing T cell clonal expansion
and was shown to be necessary for the control of RNA
and DNA viral infections in mice [37].
Mitochondrial alarmins
Mitochondria are ancient bacteria that have become
endosymbionts and then organelles specialized with the
evolution into oxygen-dependent energy producing fac-
tories (ATP production, cellular respiration) [38]. Two
important features of mitochondria are that: 1) they have
retained some molecules of bacterial origin throughout
the evolution, and 2) they escape the immune system
due to their obligatory intracellular location but can po-
tentially be recognized as non-self when they are found
extracellularly. Evidence has recently accumulated that
mitochondrial alarmins mediate inflammation [39]. It
was recently demonstrated that mitochondrial DNA (re-
sembling to bacterial DNA) was found extracellularly
after tissue injury, in the plasma from multiple trauma
patients [40]. MtDNA, like bacterial DNA, is proinflam-
matory via the activation of Toll-like receptor 9 present
in many cell types. The formulated peptide fMet-Leu-Phe
(or fMLP) is another molecule present in the wall of both
bacteria and mitochondria, but absent in any other human
structure. It was shown that the release of mitochondria
during tissue injury attracted phagocytes via the chemo-
attractant fMLP, through its ligation to the fMLP receptor
(FPR1) present at the surface of neutrophils [40]. By
far, mitochondrial DAMPs are to date the best candi-
date endogenous danger signals; they respond to all alar-
min criteria [18,41]. Injected to animals, mitochondrial
preparations induce lung injury resembling to that seen
during ARDS [40]. A schematic view of the action of
mitochondrial danger signals acting as alarmins is pro-
posed in Figure 1.
Figure 1 (See legend on next page.)
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Figure 1 Inflammation induced by alarmins released from injured/necrotic cells. A. Injured/necrotic cells with membrane breaks release
ATP and mitochondrial alarmins (mitochondrial products). B. Extracellular ATP stimulates in target (immune) cells the assembly of the NALP3
inflammasome via its interaction with the P2X7 receptor, activating caspase-1. Mitochondrial (mt)DNA stimulates the transcription of the pro-IL-1ß
gene via its interaction with TLR9 receptor, and the production of pro-IL-1ß that will be cleaved by activated caspase-1 into bioactive IL-1ß, which
in turn can be released into the alveolar space and the interstitium and generate local inflammation. fMLP will create chemotactic gradients to
attract neutrophils to the injured tissues. C. Neutrophils attracted to the injured tissues will be activated further by fMLP and IL-1ß via their
respective receptors (FPR1, and IL-1R), generate oxidative burst and release proteases, which could be further deleterious to tissues (neutrophil-
dependent tissue injury).
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Tissue injury/necrosis also releases cytoplasmic adeno-
sine triphosphate (ATP), which becomes “extracellular”
ATP (ATPec), and activates neighboring cells via the
leukocyte P2X7 receptor (Figure 1) [42]. Like uric acid,
ATPec activation of cells leads to caspase-1 activation
and maturation of IL-1ß via the assembly of the NALP3
inflammasome and participate in local inflammation
[42]. Assembling the NALP3 inflammasome probably
does not suffice to create inflammation, because the cas-
pase 1 substrates pro-IL-1ß and pro-IL-18 need to be
present to generate inflammation [43]. ATPec might
therefore be seen more as a co-alarmin, enhancing the
inflammation induced by mitochondrial alarmins or bac-
terial products such as lipopolysaccharide responsible
for the transcriptional activation of the pro-IL-1ß and
pro-IL-18 genes [43].
Conclusions
The discovery of potent endogenous danger signals released
from injured/necrotic cells clearly adds to our understand-
ing of the pathogenesis of “sterile inflammation,” as well
as SIRS when tissue injury is sufficient to produce sys-
temic inflammation. Alarmins represent nothing less than
the proximal endogenous mediators linking cell necrosis
and the inflammatory response generated by tissue injury.
The identification of alarmins from mitochondria that are
ancient bacteria sheltered inside of cells makes a lot of
sense. Mitochondria have retained throughout the evolu-
tion some molecules of their bacterial ascent that, when
found extracellularly, can be recognized as “non-self”
by cells from the immune system. Other alarmins, such as
ATP, also are strictly intracellular molecules that when
found extracellularly will be sensed as a “danger molecule,”
meaning for the immune system: “rupture of plasma cell
membrane and tissue injury.” Although extracellular ATP
does not seem to be capable of mediating a great deal of in-
flammation, it is an important cofactor, an enhancer of the
inflammatory reaction in response to mitochondrial danger
molecules and to microbial-associated molecular patterns.
Given their proximal location in the inflammatory cas-
cade during tissue inflammation, alarmins and alarmin-
dependent pathways represent attractive targets to develop
drugs aimed at dampening deleterious inflammatoryreactions following (massive) tissue injury. Examples of
such situations in critical care are: multiple trauma, ARDS,
ventilator-induced lung injury, ischemia/reperfusion injury,
and severe pancreatitis. Blocking alarmin-dependent path-
ways will certainly dampen neutrophil-dependent tissue in-
jury. It also will decrease innate immune responses and
possibly favor bacterial and yeast superinfections, because it
will interfere with the recruitment and the activation of
neutrophils. Phagocyte recruitment at the site of tissue in-
jury also plays an important role for the removal of cell
debris, the restitution of tissue integrity and healing. As
with many modulators of the inflammation, finding the
right dose of “anti-alarmins,” the proper route of adminis-
tration, and the adequate time window will be key to de-
velop successful novel drugs designed to combat SIRS and
SIRS-induced organ dysfunction.
Abbreviations
ATPec: Extracellular adenosine triphosphate; fMLP: Formyl-Met-Leu-Phe;
PIRO: Predisposition, infection, response, and organ dysfunction; IL-1RA: IL-1
receptor antagonist; DAMPs: Danger-associated molecular patterns;
HMGB1: High mobility group box 1; RAGE: Receptor for advanced glycation
end products; TLR: Toll-like receptor; HSPs: Heat shock proteins;
LPS: Lipopolysaccharide; MtDNA: Mitochondrial DNA; NALP3: NACHT, LRR
and PYD domains-containing protein 3.
Competing interests
The author declares that he has no competing interests.
Acknowledgement
This work was supported by the Swiss National Fund for Scientific Research,
grant #320080-122034 and 141143.
Received: 28 March 2012 Accepted: 15 April 2012
Published: 12 July 2012
References
1. Bone RC: Toward an epidemiology and natural history of SIRS (systemic
inflammatory response syndrome). JAMA 1992, 268:3452–3455.
2. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference
on sepsis and organ failure. Chest 1992, 101:1481–1483.
3. Pittet D, Rangel-Frausto S, Li N, et al: Systemic inflammatory response
syndrome, sepsis, severe sepsis and septic shock: incidence,
morbidities and outcomes in surgical ICU patients. Intensive Care Med
1995, 21:302–309.
4. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The
natural history of the systemic inflammatory response syndrome (SIRS) A
prospective study. JAMA 1995, 273:117–123.
5. Dear VJL: SIRS I'm sorry to say that I don't like you. Crit Care Med 1997,
25:372–374.
6. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS
International Sepsis Definitions Conference. Intensive Care Med 2003,
29:530–538.
Pugin Annals of Intensive Care 2012, 2:27 Page 6 of 6
http://www.annalsofintensivecare.com/content/2/1/277. Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI: Proof of
principle: the predisposition, infection, response, organ failure sepsis
staging system. Crit Care Med 2011, 39:322–327.
8. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the
treatment of the systemic inflammatory response syndrome. JAMA 1993,
269:1829–1835.
9. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR: Proinflammatory activity
in bronchoalveolar lavage fluids from patients with ARDS, a prominent role
for interleukin-1. Am J Respir Crit Care Med 1996, 153:1850–1856.
10. Dugernier TL, Laterre PF, Wittebole X, et al: Compartmentalization of the
inflammatory response during acute pancreatitis: correlation with local
and systemic complications. Am J Respir Crit Care Med 2003, 168:148–157.
11. Munford RS, Pugin J: Normal responses to injury prevent systemic
inflammation and can be immunosuppressive. Am J Respir Crit Care Med
2001, 163:316–321.
12. de Jong HK, van der Poll T, Wiersinga WJ: The systemic pro-inflammatory
response in sepsis. J Innate Immun 2010, 2:422–430.
13. Pugin J: Dear SIRS, the concept of "alarmins" makes a lot of sense!.
Intensive Care Med 2008, 34:218–221.
14. Matzinger P: Tolerance, danger, and the extended family. Annu Rev
Immunol 1994, 12:991–1045.
15. Matzinger P: An innate sense of danger. Ann N Y Acad Sci 2002, 961:341–342.
16. Matzinger P: The danger model: a renewed sense of self. Science 2002,
296:301–305.
17. Dreifus C: A Conversation With Polly Matzinger; Blazing an Unconventional
Trail to a New Theory of Immunity.: The New York Times; 1998.
18. Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about
danger. J Leukoc Biol 2007, 81:1–5.
19. Adib-Conquy M, Cavaillon JM: Stress molecules in sepsis and systemic
inflammatory response syndrome. FEBS Lett 2007, 581:3723–3733.
20. Oppenheim JJ, Tewary P, de la Rosa G, Yang D: Alarmins initiate host
defense. Adv Exp Med Biol 2007, 601:185–194.
21. Iyer SS, Pulskens WP, Sadler JJ, et al: Necrotic cells trigger a sterile
inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad
Sci USA 2009, 106:20388–20393.
22. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin
lethality in mice. Science 1999, 285:248–251.
23. Yang R, Harada T, Mollen KP, et al: Anti-HMGB1 neutralizing antibody
ameliorates gut barrier dysfunction and improves survival after
hemorrhagic shock. Mol Med 2006, 12:105–114.
24. Levy RM, Mollen KP, Prince JM, et al: Systemic Inflammation and Remote
Organ Injury Following Trauma Require HMGB1. Am J Physiol Regul Integr
Comp Physiol 2007, 293(4):R1538–44.
25. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, et al: Persistent
elevation of high mobility group box-1 protein (HMGB1) in patients with
severe sepsis and septic shock. Crit Care Med 2005, 33:564–573.
26. Kokkola R, Andersson A, Mullins G, et al: RAGE is the major receptor for
the proinflammatory activity of HMGB1 in rodent macrophages. Scand J
Immunol 2005, 61:1–9.
27. Yu M, Wang H, Ding A, et al: HMGB1 signals through toll-like receptor
(TLR) 4 and TLR2. Shock 2006, 26:174–179.
28. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H: Pivotal advance:
analysis of proinflammatory activity of highly purified eukaryotic
recombinant HMGB1 (amphoterin). J Leukoc Biol 2007, 81:49–58.
29. Tsan MF: Heat shock proteins and high mobility group box 1 protein lack
cytokine function. J Leukoc Biol 2011, 89:847–853.
30. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P: HMGB1:
guiding immunity from within. Trends Immunol 2005, 26:381–387.
31. Harris HE, Raucci A: Alarmin(g) news about danger: workshop on innate
danger signals and HMGB1. EMBO Rep 2006, 7:774–778.
32. Raucci A, Palumbo R, Bianchi ME: HMGB1: a signal of necrosis.
Autoimmunity 2007, 40:285–289.
33. Calderwood SK, Mambula SS, Gray PJ Jr: Extracellular heat shock proteins
in cell signaling and immunity. Ann N Y Acad Sci 2007, 1113:28–39.
34. Foell D, Wittkowski H, Roth J: Mechanisms of disease: a 'DAMP' view of
inflammatory arthritis. Nature clinical practice 2007, 3:382–390.
35. Foell D, Wittkowski H, Vogl T, Roth J: S100 proteins expressed in
phagocytes: a novel group of damage-associated molecular pattern
molecules. J Leukoc Biol 2007, 81:28–37.
36. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid
crystals activate the NALP3 inflammasome. Nature 2006, 440:237–241.37. Bonilla WV, Frohlich A, Senn K, et al: The alarmin interleukin-33 drives
protective antiviral CD8 T cell responses. Science 2012, 335:984–989.
38. Dyall SD, Brown MT, Johnson PJ: Ancient invasions: from endosymbionts
to organelles. Science 2004, 304:253–257.
39. Krysko DV, Agostinis P, Krysko O, et al: Emerging role of damage-associated
molecular patterns derived from mitochondria in inflammation.
Trends Immunol 2011, 32:157–164.
40. Zhang Q, Raoof M, Chen Y, et al: Circulating mitochondrial DAMPs cause
inflammatory responses to injury. Nature 2010, 464:104–107.
41. Jaecklin T, Otulakowski G, Kavanagh BP: Do soluble mediators cause
ventilator-induced lung injury and multi-organ failure? Intensive Care Med
2010, 36:750–757.
42. Mariathasan S, Weiss DS, Newton K, et al: Cryopyrin activates the
inflammasome in response to toxins and ATP. Nature 2006, 440:228–232.
43. McDonald B, Pittman K, Menezes GB, et al: Intravascular danger signals guide
neutrophils to sites of sterile inflammation. Science 2010, 330:362–366.
doi:10.1186/2110-5820-2-27
Cite this article as: Pugin: How tissue injury alarms the immune system
and causes a systemic inflammatory response syndrome. Annals of
Intensive Care 2012 2:27.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
